Immunogenicity and safety of a tetanus-diphtheria vaccine and a 13-valent pneumococcal conjugate vaccine after concomitant vaccination in ≥ 50-year-old adults
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.